1D4 — Aoxin Q & M Dental Cashflow Statement
0.000.00%
- SG$29.16m
- SG$19.75m
- CNY183.72m
- 67
- 87
- 59
- 86
Annual cashflow statement for Aoxin Q & M Dental, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -11.9 | -6.83 | -73 | -44.1 | -0.334 |
| Depreciation | |||||
| Amortisation | |||||
| Non-Cash Items | 9.72 | 2.58 | 64.5 | 48.4 | 15.5 |
| Unusual Items | |||||
| Equity in Net Earnings/Losses | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -3.48 | -12.3 | 6.44 | -4.23 | 0.084 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 12.4 | 1.1 | 16 | 17.8 | 30.2 |
| Capital Expenditures | -3.44 | -6.76 | -4.02 | -3.86 | -2.15 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | -2.96 | -0.234 | 23.1 | 10.5 | 0 |
| Acquisition of Business | |||||
| Sale of Business | |||||
| Sale of Fixed Assets | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -6.4 | -6.99 | 19.1 | 6.63 | -2.15 |
| Financing Cash Flow Items | -3.27 | -3.12 | -2.44 | -1.8 | -1.49 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 5.12 | -6.87 | -20.7 | -13.6 | -9.28 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 11 | -13.5 | 15.1 | 11.8 | 18.8 |